Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

UNITED THERAPEUTICS (UTHR) Equity Income: 2009-2013

Historic Equity Income for UNITED THERAPEUTICS (UTHR) over the last 4 years, with Jun 2013 value amounting to -$72,000.

  • UNITED THERAPEUTICS's Equity Income fell 71.43% to -$72,000 in Q2 2013 from the same period last year, while for Jun 2013 it was -$200,000, marking a year-over-year decrease of 75.44%. This contributed to the annual value of -$143,000 for FY2012, which is 20.17% down from last year.
  • UNITED THERAPEUTICS's Equity Income amounted to -$72,000 in Q2 2013, which was down 53.19% from -$47,000 recorded in Q1 2013.
  • In the past 5 years, UNITED THERAPEUTICS's Equity Income registered a high of -$9,000 during Q4 2011, and its lowest value of -$72,000 during Q2 2013.
  • In the last 3 years, UNITED THERAPEUTICS's Equity Income had a median value of -$39,500 in 2011 and averaged -$38,100.
  • As far as peak fluctuations go, UNITED THERAPEUTICS's Equity Income skyrocketed by 70.00% in 2011, and later plummeted by 266.67% in 2012.
  • UNITED THERAPEUTICS's Equity Income (Quarterly) stood at -$42,000 in 2009, then climbed by 28.57% to -$30,000 in 2010, then spiked by 70.00% to -$9,000 in 2011, then crashed by 266.67% to -$33,000 in 2012, then tumbled by 71.43% to -$72,000 in 2013.
  • Its Equity Income was -$72,000 in Q2 2013, compared to -$47,000 in Q1 2013 and -$33,000 in Q4 2012.